APA

Quakkelaar E. D., Fransen M. F., van Maren W. W. C., Vaneman J., Loof N. M., van Heiningen S. H., Verbeek J. S., Ossendorp F. & Melief C. J. M. (20140818). IgG-mediated anaphylaxis to a synthetic long peptide vaccine containing a B cell epitope can be avoided by slow-release formulation. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

Quakkelaar Esther D, Fransen Marieke F, van Maren Wendy W C, Vaneman Joost, Loof Nikki M, van Heiningen Sandra H, Verbeek J Sjef, Ossendorp Ferry and Melief Cornelis J M. 20140818. IgG-mediated anaphylaxis to a synthetic long peptide vaccine containing a B cell epitope can be avoided by slow-release formulation. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

Quakkelaar E. D., Fransen M. F., van Maren W. W. C., Vaneman J., Loof N. M., van Heiningen S. H., Verbeek J. S., Ossendorp F. and Melief C. J. M. (20140818). IgG-mediated anaphylaxis to a synthetic long peptide vaccine containing a B cell epitope can be avoided by slow-release formulation. : Journal of immunology (Baltimore, Md. : 1950).

MLA

Quakkelaar Esther D, Fransen Marieke F, van Maren Wendy W C, Vaneman Joost, Loof Nikki M, van Heiningen Sandra H, Verbeek J Sjef, Ossendorp Ferry and Melief Cornelis J M. IgG-mediated anaphylaxis to a synthetic long peptide vaccine containing a B cell epitope can be avoided by slow-release formulation. : Journal of immunology (Baltimore, Md. : 1950). 20140818.